iForumRx retweeted
I'm all ears 👂to hear anything @JHughesPharmD has to say!
Should a company be "rewarded" for science that extends our knowledge ... but probably applies to the entire class? Sotagliflozin studies break new ground but other SGLT2 inhibitors are the likely benefactors. @marenrichards18 and @JHughesPharmD explain. iforumrx.podbean.com/e/raise…
iForumRx retweeted
Insightful interview with Alan Zillich @purduepharmacy about getting published in biomedical journals - from idea generation, working with writing teams, handling rejection, and blocking the time. A great episode for residents and graduate students. pharmacyforward.podbean.com/…
iForumRx retweeted
#Pharmacists have the biggest role to play in recommending Environmental Protection Agency (EPA)–registered insect repellents to patients, along with instructions on how to apply them correctly
Article: ow.ly/sJem50i97RS
iForumRx retweeted
For many children and adults with primary axillary hyperhidrosis—commonly known as excessive underarm sweating—a recently approved topical product may simplify treatment. Learn more: ja.ma/2OOveJe
iForumRx retweeted
Soaring insulin prices have patients terrified and pharmacists scrambling pharmacist.com/article/soari…
iForumRx retweeted
Odds Ratios—Current Best Practice and Use @JAMA_current ja.ma/2Kc7IlP
iForumRx retweeted
Community-based #pharmacies have an opportunity to collaborate with primary care practices and can help to improve the overall health outcomes of their patients ow.ly/UQMp50iaJJQ
iForumRx retweeted
Combo pills? NNT is 200 for 1 year to avoid 1 CVA/MI. If you are a pcp, you have enough pts to make a difference. QxMD.com/r/29889841
iForumRx retweeted
Now *this* is the research that gets me jazzed. CRC screening rates improving by mailing out FIT kits NNT=4.8 (mailing per returned test). CRC screening is one of the most effective means of cancer prevention out there. #implementationresearch jamanetwork.com/journals/jam…
iForumRx retweeted
The implementation of a pharmacist‐driven TOC initiative targeting ACS patients was associated with reduced readmission rates. buff.ly/2LnIbaP
@accpcardprn
iForumRx retweeted
Tracking pharmacy quality/productivity is important, most participants report. What, how, and why metrics are collected are highly variable. A more standardized approach would be beneficial. buff.ly/2AKPk3S
@accp @accpedtrprn @stoverkr
iForumRx retweeted
Replying to @JACCPJournal
@JACCPJournal is planning a themed issue devoted to clinical pharmacy practice in community settings! Check out the full call and instructions for submissions today! onlinelibrary.wiley.com/page…
iForumRx retweeted
The CMM Study Team has released The Patient Care Process for Delivering CMM: Optimizing Medication Use in Patient-Centered, Team-Based Care Settings. This common language document ensures CMM is delivered consistently and with fidelity. Get yours today! accp.com/071803
iForumRx retweeted
Is accepting work requirements for Medicaid beneficiaries a fair trade-off for expanding Medicaid coverage in red or purple states? Andy Slavitt, MBA examines this topic in The JAMA Forum: qoo.ly/r7ked #blog
iForumRx retweeted
Chronic nonallergic rhinitis encompasses a group of rhinitis subtypes without allergic or infectious etiologies. Find out more here: ow.ly/P6DK30lfU8J
iForumRx retweeted
Find out why overtreatment of isolated subsegmental pulmonary embolism (#SSPE) is more common than clinical surveillance in this study from researchers at @mcgillu ja.ma/2AzUsYO #lessismore
iForumRx retweeted
This Viewpoint provides a clinical update on Lyme disease, reviewing information on the epidemiology, diagnosis, and treatment of the infection, and discussing the role of Lyme testing in the evaluation of chronic pain and fatigue: ja.ma/2Ozeghw
iForumRx retweeted
Pharmacy resident–run TOC pilot service at @BrighamWomens reduced high-risk CV patients' 30-day readmission rate by 20%. Find out how: bit.ly/2uNoEdn
iForumRx retweeted
JAPhA is pleased to announce that the second annual community-based residency issue is now available online
Link: ow.ly/qSUN50i6ais























